Abstract

The year 1899 can be regarded as the beginning of the production of medications for animals in the Polish territories, for it was then that biological preparations made at the Department of Hygiene of the Jagiellonian University in Kraków were first mentioned by the press. The interwar period saw the development of not only the veterinary and bioveterinary industry, but also legislation that regulated its functioning. Although very advanced for those times, those laws were also susceptible to different interpretations and could easily be circumvented. In 1939, there were 33 Polish companies producing synthetic preparations and 6 producing serums and vaccines. One serious problem of the Polish pharmaceutical industry was the deficiency of domestic investment capital. The foreign ownership of the pharmaceutical industry amounted to 30%. Polish serums and vaccines for humans and animals fully covered the country’s needs and represented the strongest branch of the domestic pharmaceutical industry (in 1939, the Polish production of medicines met 3/4 of domestic demand). The development of industrial pharmacy in Poland was stopped by the outbreak of the Second World War. Many buildings were destroyed already at the beginning of the war in 1939. Post-war years showed that the foundations of the Polish pharmaceutical industry (including its veterinary branch) were solid. Polish pharmaceutical companies mostly recovered and sometimes even expanded their productive potential after the war.

Highlights

  • The year 1899 can be regarded as the beginning of the production of medications for animals in the Polish territories, for it was that biological preparations made at the Department of Hygiene of the Jagiellonian University in Kraków were first mentioned by the press

  • The interwar period saw the development of the veterinary and bioveterinary industry, and legislation that regulated its functioning. Very advanced for those times, those laws were susceptible to different interpretations and could be circumvented

  • One serious problem of the Polish pharmaceutical industry was the deficiency of domestic investment capital

Read more

Summary

Introduction

In 1939, there were 33 Polish companies producing synthetic preparations and 6 producing serums and vaccines. Polish serums and vaccines for humans and animals fully covered the country’s needs and represented the strongest branch of the domestic pharmaceutical industry (in 1939, the Polish production of medicines met 3/4 of domestic demand). Polish pharmaceutical companies mostly recovered and sometimes even expanded their productive potential after the war.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.